EDAP has recieved FDA clearance on its prostate device. With a price target of $6 this has room to run. Shorts could get trapped. A mourning dip got caused some panic but it appears to be holding the $3.70 range and looking to setup for another break out after the rsi cools down a bit.
相关出版物
免责声明
这些信息和出版物并非旨在提供，也不构成TradingView提供或认可的任何形式的财务、投资、交易或其他类型的建议或推荐。请阅读使用条款了解更多信息。